Trial
NCT00687674
Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
National Cancer Institute (NCI)
Condition
Multiple Myeloma and Plasma Cell Neoplasm
Intervention
dexamethasone
Why stopped
Due to study design (and toxicity), this trial closed to accrual prior to opening the phase II portion.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-20